|
The Alan Rosenthal Research Fund in Hemangiopericytoma was established in May 2008 at Memorial Sloan-Kettering Cancer Center under the direction of Dr. Mary Louise Keohan. Until now no research fund has been in existence for this very rare disease. The fund will support clinical trials and help underwrite path breaking research in hemangiopericytoma and will be especially helpful to the Cancer Centers investigators who need early funding for projects that could later be eligible for support from government agencies such as the National Institute of Health. In 1995, at 31 years old, Alan Rosenthal was diagnosed
with Hemangiopericytoma. |
